|
Federal Court Upholds Pay-for-Delay in Cipro Case, but Invites Appeal
A federal appeals court has ruled that a pay-for-delay deal between Bayer and Barr Laboratories over the antibiotic Cipro does not violate federal antitrust law.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Related Articles
Union Suit Claims Warner Chilcott Schemed to Stall Generics, Push Weaker Product Teva Prepping for Potential $2 Billion Loss in Protonix Patent FlapLawmakers to SCOTUS: Congress Purposely Did Not Preempt Drugmakers From State SuitsPhRMA Joins Generic Makers in Calling for SCOTUS Reversal of Mutual Decision
|
Subscribe
Archives